Looks like you clickedhttps://investors.januxrx.com/investor-media/news/news-details/2023/Janux-Therapeutics-Announces-Positive-Interim-Clinical-Data-from-Phase-1a-Dose-Escalation-for-PSMA-TRACTr-JANX007-and-an-Update-on-Pipeline-Programs/default.aspx
If you do not want to visit that page, you can close this browser tab.
